Serine Protease Inhibitors

All categories
DBCAT000001Pharmacologic class

Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. A DrugBank category of 40 drugs. 20 of them are approved.

Part of
Protease Inhibitors
Also known as
Serine Endopeptidase Inhibitors · Serine Protease Inhibitors, Endogenous · Serine Protease Inhibitors, Exogenous · Serine Proteinase Antagonists · Serine Proteinase Inhibitors
Drugs

and 15 more with a free account

What you can answer from here — as of August 12, 2022

40DrugsEach linked to its full drug card
Sign in
48Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,442Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
8Routes of administrationHow the drugs in this class are given
Sign in
3SubcategoriesNarrower classes within this one
Sign in

Which targets do Serine Protease Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In